Literature DB >> 22802820

Moyamoya disease: Diagnostic imaging.

Eugeniusz Tarasów1, Alina Kułakowska, Adam Lukasiewicz, Katarzyna Kapica-Topczewska, Alicja Korneluk-Sadzyńska, Joanna Brzozowska, Wiesław Drozdowski.   

Abstract

Moyamoya disease is a progressive vasculopathy leading to stenosis of the main intracranial arteries. The incidence of moyamoya disease is high in Asian countries; in Europe and North America, the prevalence of the disease is considerably lower. Clinically, the disease may be of ischaemic, haemorrhagic and epileptic type. Cognitive dysfunction and behavioral disturbance are atypical symptoms of moyamoya disease.Characteristic angiographic features of the disease include stenosis or occlusion of the arteries of the circle of Willis, as well as the development of collateral vasculature. Currently, magnetic resonance angiography and CT angiography with multi-row systems are the main imaging methods of diagnostics of the entire range of vascular changes in moyamoya disease.The most common surgical treatment combines the direct arterial anastomosis between the superficial temporal artery and middle cerebral, and the indirect synangiosis involving placement of vascularised tissue in the brain cortex, in order to promote neoangiogenesis. Due to progressive changes, correct and early diagnosis is of basic significance in selecting patients for surgery, which is the only effective treatment of the disease. An appropriate qualification to surgery should be based on a comprehensive angiographic and imaging evaluation of brain structures.Despite the rare occurrence of moyamoya disease in European population, it should be considered as one of causes of ischaemic or haemorrhagic strokes, especially in young patients.

Entities:  

Keywords:  angiography; ischaemic stroke; moyamoya disease

Year:  2011        PMID: 22802820      PMCID: PMC3389911     

Source DB:  PubMed          Journal:  Pol J Radiol        ISSN: 1733-134X


Background

Moyamoya disease was first described in 1957 as a “bilateral hypoplasia of internal of internal carotid arteries” [1]. The name of the disease comes from Japanese and means ‘puff of smoke’. Commonly applied in the clinical practice, modern methods of brain vessel imaging, such as CT angiography, MR angiography, or 3D DSA (rotational digital subtraction angiography) lead to a more frequent diagnosis of asymptomatic cases of this disease. Therefore, the knowledge of radiological symptoms has a significant influence on the right diagnosis and management of patients with moyamoya disease.

Epidemiology, Aetiology and Clinical Symptoms of Moyamoya Disease

High incidence of the disease is noted mainly in Asia (in Korea and Japan predominantly), with 3 cases per 100,000 of paediatric population [2]. In non-Asian countries, the incidence is much lower - in Europe, it is ten times lower than in Japan [3,4]. In Poland, there were only single reports, and this topic has rarely been discussed in the Polish medical literature [5,6]. The aetiology of moyamoya disease is poorly understood. Genetic background is frequently mentioned because in 15% of cases, the disease is found in other family members [3]. These are most probably the cases of multifactorial autosomal inheritance. Studies by Mineharu et al. pointed to locus 17q25 as having causal relationship with the disease [7]. Genetic theory is also supported by the relationship with other genetic diseases; the disease is much more frequent in children with Down syndrome, who also reveal other vascular abnormalities, such as thrombosis of the venous sinuses [8]. Vascular lesions typical for moyamoya disease may also develop in HCV-infected individuals, patients with cryoglobulinemia, sickle-cell disease, and individuals after radiotherapy of tumours of the optic chiasm [9-11]. Cases in which the aetiological factor was determined, are termed ‘moyamoya syndrome’. However, in most of the patients, the lesions are not caused by any known risk factors, i.e. develop in healthy individuals, and are then classified as moyamoya disease [12]. The disease is most common in children and young adolescents. There are observed two peaks of incidence – in the first and 3–4 decade of life [3]. The disease is more frequent in women, and the ratio of women to men with the disease amounts to 1.8:1 [13], or even 4.25:1, according to German authors [14]. The most common clinical symptoms of the disease include: sudden onset of hemiplegia, with sensation disturbances and aphasia [15]. There may also appear headaches, vertigo, seizures and involuntary movements [16]. There were reported cases of cognitive dysfunction or psychoorganic syndrome [17]. According to the Classification of the Japanese Health Ministry, there are 4 clinical forms of the moyamoya disease: ischaemic, haemorrhagic, epileptic, and ‘other’ [16]. The ischaemic form is most common in children, while the haemorrhagic form is more popular in adults. In children, the moyamoya disease has a form of transient ischaemic attacks (TIA) or lacunar strokes, leading to mental retardation [18]. In adults, there may appear intracranial haemorrhages, including subarachnoid haemorrhages [16,19]. There were also reports on strokes of ‘the last meadow’ type in adults [19]. Rarely reported clinical symptoms include also alien limb syndrome [20]. In the European population, the disease symptoms appear mostly at a later age than in Asian countries, and the haemorrhagic lesions are less frequent [14,21]. The clinical course is variable. The disease may progress slowly, with rare stroke incidents, while in some of the cases, there is a fast progression with a sudden deterioration of the neurological status. Ischaemic incidents may repeat, especially in the first years of the disease. The risk of repeated ischaemic strokes is from 65% to 82% (for bilateral lesions) [21]. In patients from Asian countries, on the other hand, repeated haemorrhagic strokes are quite common – the risk of repeated haemorrhage amounts to 30–65% [3].

Morphological Lesions and Imaging Diagnostics in the Moyamoya Disease

Changes appearing in the course of the disease include mainly the terminal parts of internal carotid arteries and/ or proximal parts of middle and anterior cerebral arteries [13]. In the affected cerebral vessels, pathological examinations do not show atherosclerotic or inflammatory lesions and the cause of stenosis is the overgrowth of the smooth muscle layer, with thrombotic changes [22]. The disease leads not only to a different degree of stenosis and occlusions of large arteries of the anterior part of the Willis circle, but also to the development of the collateral vasculature that produces a typical angiographic image, called ‘clouds of smoke’ or ‘puff of cigarette smoke’ [12]. The vessels of the collateral circulation are formed as a result of widening of the existing vessels or development of new perforating arteries [23]. These arteries are small or medium-sized muscular arteries, branching from intracranial parts of internal carotid arteries, posterior cerebral arteries or anterior choroidal arteries. The vessels of the collateral circulation combine with distal branches of the middle cerebral arteries. There are three main pathways of collateral circulation – parenchymal, meningeal, and transdural. Collateral parenchymal vessels (described as vessels of ‘moyamoya’ type) are small, twisting, wide vessels penetrating towards the base of the brain, along the course of thalamo-striatal arteries and lenticulo-striatal arteries [13]. Transscleral anastomoses develop between the superficial temporal artery and the middle meningeal artery or the optic artery and the anterior or middle cerebral artery, perforating the dura mater [24]. In the vessels of the collateral circulation, there may appear thrombotic changes, which are the cause of ischaemic symptoms. An increased blood flow through thin collateral walls during stress, as well as the presence of microaneurysms, is the probable cause of intracranial haemorrhages [12]. Angiographic criteria of the diagnosis of moyamoya disease were established in 1998 [25]. They include stenosis or occlusion of the distal parts of intracranial internal carotid arteries and proximal parts of anterior and middle arteries, as well as the presence of collateral vasculature in the regions of the brain base, without causal disease. In case of bilateral changes, the diagnosis is considered as sure. Unilateral changes are qualified as probable. Naturally, CT examination is sufficient to diagnose ischaemic or haemorrhagic stroke in the course of the disease [26] (Figure 1). Ischaemic foci may be present in basal ganglia and in the white matter – periventricularly and subcortically [12]. In case of patients with TIA symptoms, the results of the studies are negative.
Figure 1.

A 39-year-old women, 3 years after stroke, preceded by TIAs (Case 1). CT examination – hypodense area attributable to malacia after stroke in the right temporal and occipital lobe.

The presence of occlusions or stenoses of large intracranial vessels and the presence of collateral vasculature in a routine contrast-enhanced CT should suggest a suspicion of the disease, especially in young individuals [26]. In ambiguous cases, it is indicated to carry out MRI, which not only helps in establishing the diagnosis, but also allows for a better evaluation of the range and time phase of ischaemic lesions [27] (Figure 2). The use of diffusion techniques substantially increases the diagnostic value of the MRI studies in these cases [28]. FLAIR sequence is also very useful, as it helps to diagnose the ‘ivy sign’, i.e. an increase in signal intensity along the fissures and gyri of cerebral hemispheres, resulting most probably from the reduction of the cortical flow [29] (Figure 3A, B). The MRI study is also very useful in visualising late sequelae of the previous strokes, i.e. brain atrophy and widening of the ventricular system and of the pericerebral fluid spaces [29,30].
Figure 2.

Case 1. MR study, FLAIR image in axial plane. Hyperintense lesion in the right temporal and occipital lobe.

Figure 3.

Case 2. A 35-year-old man with facial and arm paresis. MR study, FLAIR image in axial plane. Hyperintense lesion in the right basal ganglia (A). Cortical stroke in the left frontal lobe and ivy sign in the right frontal lobe (B).

Before modern angiographic examinations (such as CTA or MRA) were introduced to a wide clinical practice, the final diagnosis of the vascular changes was based on conventional angiography or digital subtraction angiography (DSA) [31]. At present, the diagnosis of the whole range of vascular changes in the course of the disease is based mainly on MRA and CTA, using multi-row systems [32-34] (Figure 4A, B). There were also single reports on the use of transcranial Doppler ultrasonography. However, this method does not have any significance in disease diagnostics [35,36].
Figure 4.

Case 1, Suzuki grades III/IV. CT angiography, 3D reconstruction. Narrowing of the distal segments of both ICAs. Narrow or locally not visible segments A1 of the anterior cerebral arteries and M1 of the middle cerebral arteries (A). Moyamoya collaterals visible only in MIP reconstruction (B).

Angiographic examinations distinguish 6 degrees of the severity of vascular changes [37]. The first degree includes only stenosis of the carotid artery. In the 2 and 3 degree, the collateral vasculature of moyamoya type develops and increases its range (Figures 5, 6). In the fourth and fifth degree, these vessels start disappearing, and in the sixth degree they become invisible (Figure 7) – the collateral vessels branch only from external carotid arteries.
Figure 5.

Case 1, Suzuki grades III/IV. MR angiography, ToF (time-of-flight) technique, MIP reconstructions in sagittal (A) and axial plane (B). No signal from either of the anterior cerebral and middle cerebral arteries. Collateral vessels of “moyamoya” type, visible at the base of the brain.

Figure 6.

Case 3, Suzuki grade III. A 33-year-old man with seizures, aphasia and right-sided hemiparesis. Angiogram of the right (A) and of the left (B) internal carotid artery. Stenosis of the distal parts of the internal carotid arteries; proximal stenosis of anterior and middle cerebral arteries; single “moyamoya” collateral circulation vessels

Figure 7.

Case 2, Suzuki grades V/VI. MR angiography, MIP reconstruction in axial plane. No signal from either of the anterior or middle cerebral arteries; collateral circulation vessels not visible.

An important issue reported on in the literature is also the quantitative evaluation of haemodynamic disturbances of the cerebral circulation in the course of the moyamoya disease, evaluated on the basis of PET, SPECT, and perfusion CT and MRI [38-41]. Comparative studies, including vascular and perfusion examinations, have shown significant correlations between the angiographic image and the regional perfusion. As the disease normally affects both internal carotid arteries, and not the posterior part of the arterial circle of Willis, the individuals with moyamoya disease experience a decrease in frontal blood flow (dominant in normal conditions), with normal or increased blood flow in occipital lobes [41,42]. On the basis of perfusion studies, it was also found out that in children with moyamoya disease there is a decrease in cerebral blood flow (CBF) and increase in cerebral blood volume (CBV) and in O2 extraction fraction (OEF), much more pronounced than in adult populations [43,44]. Moreover, it was reported that the reduction of CVR (cerebrovascular reserve) is higher in children, which was evaluated on the basis of tests with acetazolamide or CO2. Such differences may explain higher incidence of ischaemic lesions in paediatric populations – as opposed to intracranial haemorrhages, which are more often in adults [45]. The results of the studies on haemodynamic disturbances in adults are not homogeneous. The majority of papers reported disturbances similar to changes observed in children [42]. However, some of the reports did not confirm the presence of significant changes in perfusion parameters in adults [44]. These differences follow most probably from heterogeneity of the studied groups and depend on severity of changes and the presence of the collateral circulation. Piao et al. [42] found that patients with clinical symptoms of ischaemia or with collateral circulation, experience an increase in CBV and decrease in CVR, as opposed to the group of patients without a well-developed collateral vasculature. On the other hand, Nariai et al. [38] showed that in cases with ischaemic stroke or TIA, there followed an increase of CBV and OEF, while in patients with haemorrahges or TIA, there were no changes in perfusion parameters.

Conservative and Surgical Treatment

Causal treatment of the disease is not known. Cases of mild clinical course are normally treated conservatively. In severe cases, it is indicated to carry out surgery [13]. It is also indicated to administer antiplatelet medicines. Anticoagulative therapy is rarely used, due to the risk of bleeding [12]. Surgery includes direct anastomoses, indirect procedures, and combined therapies. Anastomoses are usually performed between the superficial temporal artery and the middle cerebral artery (STA-MCA, i.e. superficial temporal artery – middle cerebral artery anastomosis) [17,46]. Indirect procedures include synangiosis involving placement of vascularised tissue in the brain cortex, in order to promote neoangiogenesis. This type of procedure uses dura mater (EDAS – encephaloduroarteriosynangiosis), muscle tissue (EDAMS – encephaloduroarteriomyosynangiosis) or cranial periosteum [46]. Because procedures of this type do not prevent from recurrence of ischaemic incidents, combined therapies are advised [47]. In a large material of Japanese authors, including 140 patients treated surgically, successful results were obtained in 92.9% of cases, and complications were noted only in 2.9% of patients [45]. According to the data from the metaanalysis of Fung et al. [48], including 1156 cases, the risk of symptomatic disease recurrence after surgery amounted to merely 2.6% and was much lower than in patients treated conservatively, with 2/3 of them experiencing progression of the symptoms within 5 years of the disease process [12]. Recently, there has also been reported a successful implantation of a stent to the internal carotid artery in a young woman with moyamoya syndrome and recurrent TIA symptoms [49]. Before a planned procedure, it is indicated to evaluate the cerebral circulation in detail. Non-enhanced MRA has a high spatial resolution but does not allow for a satisfactory time-dependent evaluation of cerebral circulation. Moreover, this technique overestimates the degree of stenosis of the Willis circle arteries and underestimates the extension of the collateral vasculature [50]. Thus, it is indicated to perform CAS including all intracerebral and external carotid arteries before surgery. Such a comprehensive imaging aims at visualising all collateral vessels, in order not to injure any of them during surgery. An alternative method is the contrast-enhanced MRA with subtraction technique, which is characterised by a high time resolution, comparable with CAS [51], or examination with the use of 3T high-field-strength MR [52]. In order to evaluate the cerebrovascular reserve before the procedure, it is indicated to perform also SPECT examination with acetazolamide test, which is the main criterion of qualification for surgery [17,53]. Helpful may be also other methods of cerebral blood flow evaluation – CT perfusion, MRI or PET [40,41,43,45]. Perfusion examinations are also used to evaluate the effectiveness of the procedure and to improve haemodynamic parameters: increase of cerebrovascular reserve and decrease of CBV and OEF [43,54].

Conclusions

Despite its low incidence in the European population, the moyamoya disease should be taken into account as a possible cause of ischaemic strokes or spontaneous intracranial haemorrhages in young individuals. Surgery is the only successful method of treatment, preventing from disease recurrence. A proper qualification for surgery should base on a comprehensive angiographic and imaging evaluation of brain structures.
  53 in total

1.  Brain single photon emission tomography and hypercapnia test in testing cerebrovascular reserve capacity, in Moya moya disease.

Authors:  Pavel Sirucek; Prochazka Vaclav; Tomas Hrbac; Otto Kraft; Jana Chmelova; Jana Dvorackova
Journal:  Hell J Nucl Med       Date:  2008 Sep-Dec       Impact factor: 1.102

Review 2.  Moyamoya disease: current concepts and future perspectives.

Authors:  Satoshi Kuroda; Kiyohiro Houkin
Journal:  Lancet Neurol       Date:  2008-11       Impact factor: 44.182

3.  Moya Moya disease in a child.

Authors:  Samina Shamim; Jay Kumar; Syed Waseem Jamalvi; Alimuddin Shaikh
Journal:  J Coll Physicians Surg Pak       Date:  2008-04       Impact factor: 0.711

4.  Cerebral circulation and metabolism in adults' moyamoya disease--PET study.

Authors:  W Taki; Y Yonekawa; A Kobayashi; M Ishikawa; H Kikuchi; S Nishizawa; Y Yonekura; S Tanada; H Fukuyama
Journal:  Acta Neurochir (Wien)       Date:  1989       Impact factor: 2.216

5.  Surgical treatment of moyamoya syndrome in patients with sickle cell anemia: outcome following encephaloduroarteriosynangiosis.

Authors:  Todd C Hankinson; Leif-Erik Bohman; Geoffrey Heyer; Maureen Licursi; Saadi Ghatan; Neil A Feldstein; Richard C E Anderson
Journal:  J Neurosurg Pediatr       Date:  2008-03       Impact factor: 2.375

6.  Moyamoya disease in Europeans.

Authors:  Markus Kraemer; Wilhelm Heienbrok; Peter Berlit
Journal:  Stroke       Date:  2008-09-11       Impact factor: 7.914

7.  Moyamoya disease: MR imaging.

Authors:  I Fujisawa; R Asato; K Nishimura; K Togashi; K Itoh; S Noma; T Sagoh; S Minami; Y Nakano; Y Yonekawa
Journal:  Radiology       Date:  1987-07       Impact factor: 11.105

8.  Autosomal dominant moyamoya disease maps to chromosome 17q25.3.

Authors:  Y Mineharu; W Liu; K Inoue; N Matsuura; S Inoue; K Takenaka; H Ikeda; K Houkin; Y Takagi; K Kikuta; K Nozaki; N Hashimoto; A Koizumi
Journal:  Neurology       Date:  2008-05-07       Impact factor: 9.910

9.  Moyamoya disease: diagnosis with three-dimensional time-of-flight MR angiography.

Authors:  I Yamada; Y Matsushima; S Suzuki
Journal:  Radiology       Date:  1992-09       Impact factor: 11.105

10.  [Neurological complications in Down syndrome].

Authors:  A Chaanine; C Hugonenq; G Lena; J Mancini
Journal:  Arch Pediatr       Date:  2008-03-10       Impact factor: 1.180

View more
  7 in total

1.  Vaso-Occlusive Pain Management in a Patient With Sickle Cell Disease Associated With Moyamoya Syndrome.

Authors:  Drezelle Mills; Annie Wang; Iya Dubson
Journal:  Cureus       Date:  2022-03-30

2.  Moyamoya syndrome in hemoglobin E-beta thalassemia: A rare presentation and association.

Authors:  P N Doctor; A Choudhari; M Verma; R H Merchant
Journal:  J Postgrad Med       Date:  2018 Oct-Dec       Impact factor: 1.476

Review 3.  Phakomatoses and cutaneous manifestations associated with moyamoya disease and syndrome.

Authors:  Maja Tomaszewska; Lidia Strzelczuk-Judka; Danuta Ostalska-Nowicka; Katarzyna Jończyk-Potoczna
Journal:  Postepy Dermatol Alergol       Date:  2021-01-06       Impact factor: 1.837

4.  Novel and recurrent RNF213 variants in Japanese pediatric patients with moyamoya disease.

Authors:  Hiroyuki Akagawa; Maki Mukawa; Tadashi Nariai; Shunsuke Nomura; Yasuo Aihara; Hideaki Onda; Taku Yoneyama; Takumi Kudo; Kazutaka Sumita; Taketoshi Maehara; Takakazu Kawamata; Hidetoshi Kasuya
Journal:  Hum Genome Var       Date:  2018-01-25

5.  Vascular Remodeling in Moyamoya Angiopathy: From Peripheral Blood Mononuclear Cells to Endothelial Cells.

Authors:  Francesca Tinelli; Sara Nava; Francesco Arioli; Gloria Bedini; Emma Scelzo; Daniela Lisini; Giuseppe Faragò; Andrea Gioppo; Elisa F Ciceri; Francesco Acerbi; Paolo Ferroli; Ignazio G Vetrano; Silvia Esposito; Veronica Saletti; Chiara Pantaleoni; Federica Zibordi; Nardo Nardocci; Maria Luisa Zedde; Alessandro Pezzini; Vincenzo Di Lazzaro; Fioravante Capone; Maria Luisa Dell'Acqua; Peter Vajkoczy; Elisabeth Tournier-Lasserve; Eugenio A Parati; Anna Bersano; Laura Gatti
Journal:  Int J Mol Sci       Date:  2020-08-11       Impact factor: 5.923

6.  Moyamoya Disease-"A Puff of Smoke": A Rare Pediatric Case Report.

Authors:  Mridula Goswami; Ramanandvignesh Pandian; Sadhna Sharma
Journal:  Int J Clin Pediatr Dent       Date:  2020 Sep-Oct

7.  Hemodynamic evaluation of patients with Moyamoya Angiopathy: comparison of resting-state fMRI to breath-hold fMRI and [15O]water PET.

Authors:  Leonie Zerweck; Constantin Roder; Till-Karsten Hauser; Johannes Thurow; Annerose Mengel; Marcos Tatagiba; Nadia Khan; Philipp T Meyer; Ulrike Ernemann; Uwe Klose
Journal:  Neuroradiology       Date:  2021-09-27       Impact factor: 2.804

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.